+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Carcinoma Drug"

From
Adrenocortical Carcinoma Market Report 2026 - Product Thumbnail Image

Adrenocortical Carcinoma Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Adenoid Cystic Carcinoma Pipeline Analysis Report 2025 - Product Thumbnail Image

Adenoid Cystic Carcinoma Pipeline Analysis Report 2025

  • Report
  • March 2026
  • 200 Pages
  • Global
From
From
From
From
Thymic Carcinoma Pipeline Analysis Report 2026 - Product Thumbnail Image

Thymic Carcinoma Pipeline Analysis Report 2026

  • Report
  • May 2026
  • 200 Pages
  • Global
From
Hedgehog Pathway Inhibitors Market - Global Forecast 2026-2032 - Product Thumbnail Image

Hedgehog Pathway Inhibitors Market - Global Forecast 2026-2032

  • Report
  • August 2026
  • 188 Pages
  • Global
From
Oral Cancer Treatment Market - Global Forecast 2026-2032 - Product Thumbnail Image

Oral Cancer Treatment Market - Global Forecast 2026-2032

  • Report
  • August 2026
  • 199 Pages
  • Global
From
Liver Cancer Drugs Market - Global Forecast 2026-2032 - Product Thumbnail Image

Liver Cancer Drugs Market - Global Forecast 2026-2032

  • Report
  • August 2026
  • 192 Pages
  • Global
From
From
Head & Neck Cancer Drugs Market - Global Forecast 2026-2032 - Product Thumbnail Image

Head & Neck Cancer Drugs Market - Global Forecast 2026-2032

  • Report
  • August 2026
  • 184 Pages
  • Global
From
Thyroid Cancer Drugs Market - Global Forecast 2026-2032 - Product Thumbnail Image

Thyroid Cancer Drugs Market - Global Forecast 2026-2032

  • Report
  • August 2026
  • 183 Pages
  • Global
From
Cancer Immunotherapy Drugs Market - Global Forecast 2026-2032 - Product Thumbnail Image

Cancer Immunotherapy Drugs Market - Global Forecast 2026-2032

  • Report
  • August 2026
  • 188 Pages
  • Global
From
Cellular Immunotherapy Market - Global Forecast 2026-2032 - Product Thumbnail Image

Cellular Immunotherapy Market - Global Forecast 2026-2032

  • Report
  • August 2026
  • 193 Pages
  • Global
From
Neuroendocrine Carcinoma Market Report 2026 - Product Thumbnail Image

Neuroendocrine Carcinoma Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
From
Loading Indicator

Carcinoma drugs are a type of oncology drug used to treat cancer. They are designed to target and destroy cancer cells while minimizing damage to healthy cells. Carcinoma drugs can be administered orally, intravenously, or topically, depending on the type of cancer being treated. Common types of carcinoma drugs include chemotherapy, targeted therapy, immunotherapy, and hormone therapy. Chemotherapy is a type of carcinoma drug that uses drugs to kill cancer cells. Targeted therapy is a type of drug that targets specific molecules in cancer cells, such as proteins or genes, to stop the growth and spread of cancer. Immunotherapy is a type of drug that helps the body’s immune system fight cancer. Hormone therapy is a type of drug that blocks hormones that can cause cancer cells to grow. The carcinoma drug market is highly competitive, with many companies offering a variety of treatments. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. Other companies in the market include AstraZeneca, Eli Lilly, GlaxoSmithKline, and Sanofi. Show Less Read more